Ruijin Hospital Hainan is the Hainan branch of Ruijin Hospital Shanghai — one of China's top-tier academic medical centers. Operating within the Boao Lecheng International Medical Tourism Pilot Zone since 2021, it combines Ruijin's clinical excellence in oncology, haematology, and rare diseases with a regulatory framework that allows overseas-approved drugs and medical devices to be administered 2–3 years before their NMPA approval in mainland China. For the right case — particularly where an overseas-approved treatment isn't yet available elsewhere in China — it may be a suitable option. China Care helps you work out whether it's the right fit for your situation before you travel.
Ruijin Hospital (Ruijin Shanghai) holds a national ranking in the top three Chinese hospitals, with particular strength in haematology, endocrinology, general internal medicine, and complex oncology. Its Hainan branch — Ruijin Hospital Hainan (瑞金医院海南医院) — was established in the Boao Lecheng International Medical Tourism Pilot Zone in 2021, bringing the same clinical standards to a location that benefits from the zone's unique regulatory policy.
The Lecheng zone was established by the Chinese government to allow overseas-approved drugs and medical devices to be used 2–3 years before they receive NMPA approval in mainland China. This is the key clinical differentiator of Ruijin Hainan: patients can access treatments that are already approved and proven in the US, EU, or Japan but not yet available at any other hospital in China.
Hainan island also allows visa-free entry for nationals of 59+ countries, simplifying arrival for international patients compared to the medical visa process required for mainland Chinese hospitals. For cancer treatment in China and complex rare disease care, this combination — world-class clinical standards, early-access medicines, and straightforward entry — makes Ruijin Hainan a compelling access point.
Ruijin Hospital is the parent institution and consistently ranks among China's top three hospitals in haematology, endocrinology, and internal medicine. The Hainan branch operates under Ruijin's clinical protocols, with specialist physicians from the Shanghai main campus involved in complex case management. International patients receive clinical care aligned with the same standards as patients at the main Ruijin campus in Shanghai.
Under the Lecheng zone policy, Ruijin Hainan can administer drugs and devices that have received approval from the US FDA, EMA (EU), or Japan's PMDA but have not yet completed NMPA approval in mainland China. For oncology and rare disease patients, this can mean access to newer targeted therapies, immunotherapy combinations, or rare disease treatments that are simply not available at any other Chinese hospital — including the main Ruijin campus in Shanghai. This is the most clinically significant advantage of the Lecheng zone.
Ruijin Shanghai has built decades of expertise in haematological and endocrinological rare diseases. The Hainan branch inherits this diagnostic and management capability in a setting where the drug access policy is particularly relevant for rare conditions — since drugs for rare diseases are among the most likely to be approved internationally years before NMPA mainland listing. For patients with unusual diagnoses requiring specialist input and potentially cutting-edge therapeutics, Ruijin Hainan combines the right expertise with the right access.
Finding a hospital's name is easy. Knowing whether it's actually the right one for your situation is much harder — that's where China Care helps.
Most international patients researching Ruijin Hainan are unsure whether it's genuinely the right fit for their case, or whether another hospital might serve them better. China Care helps you answer questions like:
Ruijin Hainan covers Ruijin Shanghai's core clinical strengths within the Lecheng zone framework. All specialties below can potentially benefit from the early-access drug policy.
Finding a hospital is the easy part. Understanding whether it's the right one for your situation is harder — China Care guides you through that, from initial guidance through to on-the-ground support in the Boao Lecheng zone.
Share your diagnosis, pathology, imaging, and any previous treatment records. For patients interested in a specific Lecheng-zone early-access treatment, include details of the drug or device you have been advised may be available under the zone scheme. This step is free and helps us understand whether Ruijin Hainan — or another hospital — may be worth exploring for your case. China Care prepares a bilingual case summary within 1–2 working days.
records review · 1–2 daysIf it makes sense to go further, Hospital Access looks into whether Ruijin Hainan is genuinely a suitable option for your case — before you commit to travelling. Depending on your situation, this may include medical record review, department identification, specialist discussion, and a proxy consultation with the relevant specialist where appropriate — China Care attends Ruijin Hainan in person on your behalf, and for cases involving early-access medicines under the Lecheng zone policy, the doctor will confirm eligibility at this stage. The outcome is reported back to you. This is a fixed-fee service, agreed with you upfront.
Already in China or already in Hainan? Skip this step — China Care can arrange direct escort and interpretation for your own visit instead.
Hospital Access · fixed fee · Lecheng drug eligibility confirmedInternational patients from over 59 nationalities can enter Hainan visa-free for up to 30 days. This is a significant practical advantage compared to mainland Chinese hospital access, which requires a formal medical visa. China Care advises you on the applicable entry rules based on your nationality. Fly into Boao Airport or Haikou Meilan International Airport.
visa-free 59+ nationalities · 30-day entryYour in-person specialist consultation confirms the treatment plan. Treatment is then delivered according to the agreed schedule. All treatment fees are paid directly to the hospital in RMB. Lecheng-zone pricing applies. A deposit is typically required on admission.
in-person consultation · RMB direct to hospitalEnd-of-treatment review, bilingual discharge documentation, and a structured follow-up plan. China Care ensures all records are prepared in a format compatible with your home clinician's requirements, including documentation of any Lecheng zone drugs administered.
bilingual discharge · post-treatment supportWhichever stage you're at, China Care's role is the same: help you make an informed decision, not just a booking.
Records review, specialist matching, and appointment coordination — confirming whether Ruijin Hainan or another hospital is the right fit before you commit to travel.
Learn more →Support before, during, and after treatment in China — from admission through to follow-up care.
Learn more →We'll help you understand whether Ruijin Hainan — or another hospital in China — may be a better option for your situation.
Treatment costs are quoted directly by Ruijin Hospital Hainan. We never add to or mark up the hospital's quoted treatment cost. Visa-free entry to Hainan for nationals of 59+ countries.
Hospital profile note: This profile is general reference information. China Care does not endorse or guarantee a particular hospital, treatment, appointment, clinical decision, or outcome. Current services, requirements, language support, availability, and clinical suitability should be confirmed directly with the hospital.